Picture of Phaarmasia logo

523620 Phaarmasia Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapHigh Flyer

Momentum

Relative Strength (%)
1m+36.31%
3m+55.16%
6m+18.26%
1yr+54.93%
Volume Change (%)
10d/3m+22.83%
Price vs... (%)
52w Highn/a
50d MA+30.24%
200d MA+56.64%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.36
Price to Tang. Book3.37
Price to Free Cashflow465.57
Price to Sales1.13
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-11.05%
Return on Equity-4.91%
Operating Margin-3.8%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Phaarmasia EPS forecast chart

Profile Summary

Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCP’s). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include hormone products and herbal products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.

Directors

    Last Annual
    March 31st, 2024
    Last Interim
    March 31st, 2024
    Incorporated
    February 6th, 1981
    Public Since
    July 27th, 1992
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    in flag iconBombay Stock Exchange
    Shares in Issue
    6,826,960

    523620 Share Price Performance

    Upcoming Events for 523620

    Phaarmasia Ltd Annual Shareholders Meeting

    Q1 2025 Phaarmasia Ltd Earnings Release

    Q2 2025 Phaarmasia Ltd Earnings Release

    Similar to 523620

    Picture of Achyut Healthcare logo

    Achyut Healthcare

    in flag iconBombay Stock Exchange

    Picture of Adline Chem Lab logo

    Adline Chem Lab

    in flag iconBombay Stock Exchange

    Picture of MPS Pharmaa logo

    MPS Pharmaa

    in flag iconBombay Stock Exchange

    Picture of Albert David logo

    Albert David

    in flag iconBombay Stock Exchange

    Picture of Ambalal Sarabhai Enterprises logo

    Ambalal Sarabhai Enterprises

    in flag iconBombay Stock Exchange

    FAQ